TON - May/June 2014 Vol 7 No 3

Skin Toxicity With Targeted Agents
As a result of epidermal growth factor receptor inhibitors, many patients experience rash as an adverse event. Such skin toxicities may lead to bacterial, viral or fungal infections, as well as ocular complications. Read More ›

Highlights From the American Association for Cancer Research Annual Meeting
The American Association for Cancer Research (AACR) held its annual meeting in San Diego, California, April 5-9, 2014. The following are brief reports on some highlights from the meeting related to cancer risk and health-related behaviors. Read More ›

With little information in the literature, oncology professionals may feel insecure about the use of chemotherapy in a pregnant patient. Read More ›

Updates to ONS Chemotherapy and Biotherapy Guidelines
At the ONS 39th Annual Congress, Martha Polovich, PhD, RN, AOCN, of Georgia State University in Jonesboro, and MiKaela Olsen, MS, RN, AOCNS, of Johns Hopkins Hospital in Baltimore, Maryland, reviewed important changes in the new guidelines. Read More ›

Cancer care in the United States is reaching crisis proportions, with costs spiraling out of control and some patients getting suboptimal care. Read More ›

The Oncology Nursing Society (ONS) is gearing up to launch its “Get Up, Get Moving” campaign in the fourth quarter of 2014. This initiative is aimed at increasing physical activity in patients with cancer, with the goal of improving outcomes. Read More ›

Genetic counseling as a profession began in 1969 with the establishment of the first master’s level graduate program in genetic counseling; as a process, however, it has evolved over a longer period of time. Read More ›

It’s a busy time in the world of oncology as this issue of The Oncology Nurse-APN/PA (TON) comes together... Read More ›

When the fourth Illumina Discovery Symposium was presented in San Diego in conjunction with the 2014 meeting of the American Association for Cancer Research (AACR), I was fortunate to be invited to attend. The symposium focused on the progress being made in monitoring cancer through next-generation sequencing technologies. From my perspective as a patient advocate, there were several issues, concerns, and insights presented that caught my attention. Read More ›

The Cancer Hospital of New Jersey at Robert Wood Johnson University Hospital (RWJUH) is the flagship hospital of the Rutgers Cancer Institute of New Jersey. It is the only comprehensive cancer center in New Jersey designated by the National Cancer Institute. Read More ›


Subscribe to The Oncology Nurse-APN/PA

To sign up for our newsletter or print publications, enter your contact information below.

I'd like to receive: